STAT1 and neoplasm: Previous studies confirmed that the STAT1 protein can be promoted through the activation of classical interferon‐gamma signaling pathway.[28, 29, 30] However, low STAT1 expression correlates with lower proliferation, migration, invasion, and tumor growth, suggesting that the overexpression of STAT1 after HTR2B activation might undermine therapeutic efficacy.